In zest or jest? Will live for 130 years, perhaps more, Dalai Lama tells followers
DHARAMSHALA: A day before his 90th birthday and amid talks of succession,
Tibetan spiritual leader
the Dalai Lama Saturday said he hoped to live beyond 130 years.
Addressing devotees during a long-life prayer ceremony held by Central Tibetan Administration at main Tibetan temple in McLeodganj, he said, "So far, I believe I have served Buddha Dharma and the Tibetan people quite well.
.. I hope to live for another 30 or 40 years - even over 130."
The Tibetan spiritual master - known for his scientific temperament - has often laughed off in his trademark humour any talk about his years on Earth, each time giving different figures.
In Dec 2024, he had said he might live for 110 years or more. Five years before that, he assured his followers he would live beyond 113 years.
CTA president Penpa Tsering told TOI, "It is very difficult to interpret what His Holiness says... We believe every word he speaks."
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India.com
a day ago
- India.com
Gautam Adani makes big announcement, to invest Rs 600000000000 in world-class affordable...
Another masterstroke by Gautam Adani Gautam Adani announces healthcare sector move: In a massive step towards improving multidisciplinary healthcare ecosystem in India, Billionaire Gautam Adani on Friday revealed plans to build an AI-first, multidisciplinary healthcare ecosystem that integrates affordability, scalability, and global best practices, as he shared his vision for transforming healthcare in India. As per a report covered by PTI news agency, Gautam Adani called for a complete system-wide redesign to meet the needs of the future while he was speaking at the 5th Annual Conference of the Society for Minimally Invasive Spine Surgery – Asia Pacific (SMISS-AP). Adani, who heads ports-to-energy conglomerate, said three years ago, on his 60th birthday, his family pledged Rs 60,000 crore towards healthcare, education, and skill development. Why Gautam Adani is entering Healthcare sector? 'We did not enter healthcare because it lacked momentum. We entered because the momentum was not enough,' Gautam Adani said. 'The pace of change was out of step with the urgency of future demands. As the landscape unfolded, one truth stood out – healthcare does not need incremental upgrades. It needs a system-wide redesign. Not an evolution but a revolution rooted in intelligence as well as empathy.' Why Adani highlighted low back pain issue? Gautam Adani Citing highlighted the low back pain as a leading cause of disability in India. Saying that the back pain issue is a crisis more widespread than diabetes or heart disease – he said: 'If we are to carry the full weight of our national ambition, we must first heal the spine of our people.' Referring to the previously announced Adani Healthcare Temples – large, 1,000-bed integrated medical campuses to be established first in Ahmedabad and Mumbai – Adani said they would be 'world-class, affordable, AI-first healthcare ecosystems' and would comprise 'modular, scalable infrastructure of the kind that can expand rapidly in the face of pandemics or emergencies.' Billionaire Adani also urged the assembled global gathering of spine surgeons and specialists to become not only medical leaders but nation-builders. (With inputs from agencies)
Time of India
2 days ago
- Time of India
US: Arizona resident dies from plague, 1st in 2 decades
Representative image (AP) A resident of Coconino County, Arizona, died from pneumonic plague, the first such death in the county in almost two decades, officials said Friday. The resident went to Flagstaff Medical Centre recently and died the same day despite attempts to provide "lifesaving resuscitation," according to a statement from Northern Arizona Healthcare, which runs the hospital. Test confirmed the patient was infected with Yersinia pestis, the bacteria that causes the pneumonic plague, which appears as a severe lung infection. It was the first recorded death from pneumonic plague in Coconino County since 2007, officials said. The risk of exposure to the plague remains low, officials said. It's rare for cases of the disease to appear in humans, according to the federal Centers for Disease Control and Prevention.
Hindustan Times
2 days ago
- Hindustan Times
Trump's budget cuts for US aid halt HIV vaccine research in South Africa
Just a week had remained before scientists in South Africa were to begin clinical trials of an HIV vaccine, and hopes were high for another step toward limiting one of history's deadliest pandemics. Then the email arrived. The research project, called BRILLIANT, was meant to be the latest to draw on the region's genetic diversity and deep expertise in the hope of benefiting people everywhere.(AP/Representational) Stop all work, it said. The United States under the Trump administration was withdrawing all its funding. The news devastated the researchers, who live and work in a region where more people live with HIV than anywhere else in the world. Their research project, called BRILLIANT, was meant to be the latest to draw on the region's genetic diversity and deep expertise in the hope of benefiting people everywhere. But the $46 million from the U.S. for the project was disappearing, part of the dismantling of foreign aid by the world's biggest donor earlier this year as President Donald Trump announced a focus on priorities at home. South Africa hit hard by aid cuts South Africa has been hit especially hard because of Trump's baseless claims about the targeting of the country's white Afrikaner minority. The country had been receiving about $400 million a year via USAID and the HIV-focused PEPFAR. Now that's gone. Glenda Grey, who heads the Brilliant program, said the African continent has been vital to the development of HIV medication, and the U.S. cuts threaten its capability to do such work in the future. Significant advances have included clinical trials for lenacapavir, the world's only twice-a-year shot to prevent HIV, recently approved for use by the U.S. Food and Drug Administration. One study to show its efficacy involved young South Africans. 'We do the trials better, faster and cheaper than anywhere else in the world, and so without South Africa as part of these programs, the world, in my opinion, is much poorer,' Gray said. She noted that during the urgency of the COVID-19 pandemic, South Africa played a crucial role by testing the Johnson & Johnson and Novavax vaccines, and South African scientists' genomic surveillance led to the identification of an important variant. Labs empty and thousands are laid off A team of researchers at the University of the Witwatersrand has been part of the unit developing the HIV vaccines for the trials. Inside the Wits laboratory, technician Nozipho Mlotshwa was among the young people in white gowns working on samples, but she may soon be out of a job. Her position is grant-funded. She uses her salary to support her family and fund her studies in a country where youth unemployment hovers around 46%. 'It's very sad and devastating, honestly," she said of the U.S. cuts and overall uncertainty. 'We'll also miss out collaborating with other scientists across the continent.' Professor Abdullah Ely leads the team of researchers. He said the work had promising results indicating that the vaccines were producing an immune response. But now that momentum, he said, has 'all kind of had to come to a halt.' The BRILLIANT program is scrambling to find money to save the project. The purchase of key equipment has stopped. South Africa's health department says about 100 researchers for that program and others related to HIV have been laid off. Funding for postdoctoral students involved in experiments for the projects is at risk. South Africa's government has estimated that universities and science councils could lose about $107 million in U.S. research funding over the next five years due to the aid cuts, which affect not only work on HIV but also tuberculosis — another disease with a high number of cases in the country. Less money, and less data on what's affected South Africa's government has said it will be very difficult to find funding to replace the U.S. support. And now the number of HIV infections will grow. Medication is more difficult to obtain. At least 8,000 health workers in South Africa's HIV program have already been laid off, the government has said. Also gone are the data collectors who tracked patients and their care, as well as HIV counselors who could reach vulnerable patients in rural communities. For researchers, Universities South Africa, an umbrella body, has applied to the national treasury for over $110 million for projects at some of the largest schools. During a visit to South Africa in June, UNAIDS executive director Winnie Byanyima was well aware of the stakes, and the lives at risk, as research and health care struggle in South Africa and across Africa at large. Other countries that were highly dependent on U.S. funding including Zambia, Nigeria, Burundi and Ivory Coast are already increasing their own resources, she said. 'But let's be clear, what they are putting down will not be funding in the same way that the American resources were funding," Byanyima said.
